NCT06151730
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +30 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Clinical trial condition
Marginal Zone Lymphoma
Explore clinical trials studying Marginal Zone Lymphoma. Study availability and eligibility vary by location and protocol.
115 public trials
42 recruiting studies
Marginal Zone Lymphoma trial results
Recruiting
Optimize Study - Orelabrutinib Combined With BR/G in Untreated Marginal Zone Lymphoma (MZL)
NCT06504940
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- The First Affiliated Hospital ，Zhejiang University School of Medicine Hangzhou, Zhejiang, China
NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
NCT07029217
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Memorial Sloan Kettering Basking Ridge (All Protocol Activities) Basking Ridge, New Jersey, United States
- Memorial Sloan Kettering Monmouth (All Protocol Activities) Middletown, New Jersey, United States
- Memorial Sloan Kettering Bergen (All Protocol Activities) Montvale, New Jersey, United States
- Memorial Sloan Kettering Suffolk - Commack (All Protocol Activities) Commack, New York, United States
Recruiting
Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.
NCT04775745
- Conditions
- Blood Protein Disorders, CLL/SLL, Cardiovascular Diseases, +28 more
- Locations
-
- Duke Univerisity Durham, North Carolina, United States
- University of Cincinnati Cincinnati, Ohio, United States
- Ohio State University Columbus, Ohio, United States
- Huntsman Cancer Institute, University of Utah Salt Lake City, Utah, United States
NCT04883437
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +18 more
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
NCT06350318
- Conditions
- B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
NCT04669171
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
- University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
NCT05602363
- Conditions
- B-cell Malignancy, Blood Protein Disorders, Cardiovascular Diseases, +34 more
- Locations
-
- UC Irvine Health Orange, California, United States
- Mount Sinai Comprehensive Cancer Center Miami Beach, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern Memorial Hospital Chicago, Illinois, United States
NCT06390956
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Washington University St Louis, Missouri, United States
- Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States